Pages that link to "Q36412756"
Jump to navigation
Jump to search
The following pages link to Estrogen receptors as therapeutic targets in breast cancer (Q36412756):
Displaying 50 items.
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer (Q27852630) (← links)
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer (Q27852637) (← links)
- TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer (Q27853155) (← links)
- ApoptomiRs of Breast Cancer: Basics to Clinics (Q28072414) (← links)
- Extranuclear coactivator signaling confers insensitivity to tamoxifen (Q28246263) (← links)
- Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway (Q28281599) (← links)
- Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells (Q28282169) (← links)
- Significance of ER–Src axis in hormonal therapy resistance (Q28301805) (← links)
- Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments (Q28477774) (← links)
- Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer (Q30419997) (← links)
- Proteomics in clinical trials and practice: present uses and future promise (Q33245305) (← links)
- Heat shock protein90 in lobular neoplasia of the breast (Q33379951) (← links)
- Genetically engineered ERα-positive breast cancer mouse models (Q33578641) (← links)
- Regulation of hormonal therapy resistance by cell cycle machinery (Q33635621) (← links)
- Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30. (Q33640444) (← links)
- Comparative methods for analysis of protein covalent modification by electrophilic quinoids formed from xenobiotics (Q33682246) (← links)
- In vivo effects of a GPR30 antagonist (Q33828472) (← links)
- Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review (Q34271979) (← links)
- RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models (Q34484450) (← links)
- Roles of prohibitin in growth control and tumor suppression in human cancers (Q34497715) (← links)
- A screening cascade to identify ERβ ligands (Q34564793) (← links)
- Effects of Celecoxib and Ly117018 Combination on Human Breast Cancer Cells in Vitro (Q34908885) (← links)
- Silencing MED1 sensitizes breast cancer cells to pure anti-estrogen fulvestrant in vitro and in vivo (Q34923304) (← links)
- Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes. (Q34930830) (← links)
- MicroRNA-mediated drug resistance in breast cancer (Q35165126) (← links)
- Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant (Q35663909) (← links)
- International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators (Q35795751) (← links)
- Identification and characterization of lipopolysaccharide binding protein (LBP) as an estrogen receptor α specific serum biomarker (Q35847077) (← links)
- Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine (Q35856599) (← links)
- Inhibition of estrogen-induced mammary tumor formation in MMTV-aromatase transgenic mice by 4-chlorophenylacetate. (Q35925387) (← links)
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways (Q35930474) (← links)
- Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134). (Q36052496) (← links)
- p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells. (Q36216301) (← links)
- Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer (Q36445441) (← links)
- Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR. (Q36529877) (← links)
- RORα, a potential tumor suppressor and therapeutic target of breast cancer (Q36538295) (← links)
- Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast Cells (Q36587317) (← links)
- Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. (Q36621171) (← links)
- Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis (Q36643119) (← links)
- Promoter hypermethylation of estrogen receptor alpha gene is correlated to estrogen receptor negativity in Iranian patients with sporadic breast cancer. (Q36645071) (← links)
- Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer (Q36684234) (← links)
- Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER breast cancer (Q36689052) (← links)
- The ins and outs of GPR30: a transmembrane estrogen receptor (Q36787619) (← links)
- The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer (Q36880048) (← links)
- Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface (Q36895738) (← links)
- Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant (Q36907216) (← links)
- New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer (Q36927087) (← links)
- MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands (Q36983310) (← links)
- Linkage effects on binding affinity and activation of GPR30 and estrogen receptors ERalpha/beta with tridentate pyridin-2-yl hydrazine tricarbonyl-Re/(99m)Tc(I) chelates. (Q36999515) (← links)
- Transcriptional cross talk between orphan nuclear receptor ERRγ and transmembrane transcription factor ATF6α coordinates endoplasmic reticulum stress response. (Q37080357) (← links)